Romee receives career development award

Rizwan Romee, MD, assistant professor of medicine, has received a three-year, $200,000 career development award from the Conquer Cancer Foundation of the American Society of Clinical Oncology.

Two share NIH grant on blood-vessel research

Jessica Wagenseil, DSc, associate professor of mechanical engineering in the School of Engineering & Applied Science at Washington University in St. Louis, and Robert Mecham, PhD, the Alumni Endowed Professor of Cell Biology and Physiology at the School of Medicine and professor of medicine, of pediatrics and of biomedical engineering, received a four-year, $381,250 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) for research titled “Vessel Stiffening, Hypertension and Vascular Extracellular Matrix.”

Project ARK to provide HIV testing, area for youth at PrideFest

Project ARK , a Washington University School of Medicine program that provides health-care and support services for children and teens with HIV, will host an area designated for youth at St. Louis’ annual PrideFest, a three-day event downtown that begins Friday. Among activities at the site will be free HIV testing for anyone 25 or younger.
A person’s diet, acidity of urine may affect susceptibility to UTIs

A person’s diet, acidity of urine may affect susceptibility to UTIs

The acidity of urine — as well as the presence of small molecules related to diet — may influence how well bacteria can grow in the urinary tract, a new study shows. The research, led by Jeffrey Henderson, MD, PhD, at Washington University School of Medicine in St. Louis, may have implications for treating urinary tract infections, which are among the most common bacterial infections worldwide.

Potential treatment target identified for rare form of diabetes

Scientists working to find treatments for a severe form of diabetes called Wolfram syndrome have identified a gatekeeper in cells that prevents harmful molecules from spilling into places where they don’t belong and triggering cell death. The researchers, at Washington University School of Medicine, also found that the gatekeeper may be a good treatment target for other disorders caused by cellular stress.
View More Stories